Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -224,370 | -142,195 | -65,581 | -223,858 | -153,106 |
| Depreciation Amortization | -553 | -514 | -477 | -6,610 | -5,330 |
| Accounts receivable | N/A | -40,000 | N/A | 15,000 | 15,000 |
| Accounts payable and accrued liabilities | -483 | -216 | 3,917 | -307 | 198 |
| Other Working Capital | 9,473 | -25,974 | -27,325 | -23,970 | -20,419 |
| Other Operating Activity | 49,789 | 69,865 | 10,316 | 45,244 | 30,940 |
| Operating Cash Flow | $-166,144 | $-139,034 | $-79,150 | $-194,501 | $-132,717 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,343 | -1,162 | -467 | -12,838 | -11,902 |
| Purchase Of Investment | -509,465 | -141,907 | -83,656 | -901,226 | -822,804 |
| Sale Of Investment | 384,145 | 251,705 | 132,738 | 509,987 | 362,061 |
| Investing Cash Flow | $-126,663 | $108,636 | $48,615 | $-404,077 | $-472,645 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,078 | -659 | -277 | -1,576 | -1,283 |
| Common Stock Issued | 286,572 | 246,643 | 535 | 610,427 | 607,369 |
| Financing Cash Flow | $285,494 | $245,984 | $258 | $608,851 | $606,086 |
| Beginning Cash Position | 126,050 | 126,050 | 126,050 | 115,777 | 115,777 |
| End Cash Position | 118,737 | 341,636 | 95,773 | 126,050 | 116,501 |
| Net Cash Flow | $-7,313 | $215,586 | $-30,277 | $10,273 | $724 |
| Free Cash Flow | |||||
| Operating Cash Flow | -166,144 | -139,034 | -79,150 | -194,501 | -132,717 |
| Capital Expenditure | -1,343 | -1,162 | -467 | -12,838 | -11,902 |
| Free Cash Flow | -167,487 | -140,196 | -79,617 | -207,339 | -144,619 |